Phathom Pharmaceuticals (PHAT) Stock Insights

PHAT price $6.28 +0.29 +4.84%

Ticker
PHAT
Price
$6.28
Change
+0.29 +4.84%
Market cap ?
$508.06M
P/E ?
-4.48
Forward P/E ?
8.76
Dividend yield ?
0.00%
Beta ?
0.50
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
60
Quality
44
Growth
100

Stocklytics score rationale: value 60, quality 44, growth 100.

Financials

20182019202020212022202320242025
0000068200055252000175110000

Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments. A pivotal asset for the company is vonoprazan, a distinctive potassium-competitive acid blocker (P-CAB) designed to effectively inhibit gastric acid production, for which Phathom holds commercial rights across the United States, Europe, and Canada…

Fair value

PHAT fair value $30.53. Price $6.28. Price is 79% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 52.30M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 80.90M. Net debt 81.83M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare PHAT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—-0.11—84.82M
2026-07-30-0.21-0.1874.27M73.23M
2026-04-30-0.37-0.2758.30M55.90M
2026-02-26-0.29-0.3257.58M57.17M
2025-10-30-0.41-0.4049.50M46.99M
2025-08-07-0.79-0.7639.50M46.77M
2025-05-01-1.07-1.0628.52M35.65M
2025-03-06-0.79-1.2929.66M29.04M
2024-11-07-1.32-1.5716.35M25.77M
2024-08-08-1.25-1.207.32M5.81M
2024-05-09-1.42-1.431.91M2.05M
2024-03-07-1.39-1.08682.00K400.89K
2023-11-09-0.76-0.95—800.00K
2023-08-10-0.84-0.95——
2023-05-10-0.89-1.34——
2023-02-28-1.33-1.50—200.00K
2022-11-08-1.32-1.32——
2022-08-02-1.33-1.03——
2022-05-10-1.07-0.97—211.00K
2022-03-01-0.95-0.86——
2021-11-08-0.98-0.78——
2021-08-10-1.00-1.07——
2021-05-11-0.96-1.11——
2021-03-30-1.58-0.93——
2020-11-10-1.02-0.68——
2020-08-06-0.64-0.56——
2020-05-12-0.62-0.59——
2020-03-19-3.97-1.25——
2019-11-25-9.30-1.14——
2019-10-28-10.23———
2019-03-31-0.15———
2018-12-31-0.06———
2018-09-30-0.03———
2018-06-30-0.05———
2018-03-31-0.05———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-06Narula SanjeevSell13.48K$6.7891.43K
2026-09-03Breedlove Robert CharlesSell460$9.054.16K
2026-07-14Breedlove Robert CharlesSell1.55K$11.0417.16K
2026-05-22Parikh AsitBuy28.00K——
2026-05-22Parikh AsitSell28.00K——
2026-05-20Parikh AsitBuy17.50K$4.9586.62K
2026-05-20Parikh AsitSell17.50K$4.9586.62K
2026-05-19Parikh AsitBuy24.12K——
2026-05-19Topper James NBuy24.12K——
2026-05-19Stenhouse MarkBuy24.12K——
2026-05-19FIELDS HEIDIBuy24.12K——
2026-05-19COLA MICHAEL FBuy24.12K——
2026-05-19KARBE FRANKBuy24.12K——
2026-05-19Schroeder Theodore RBuy24.12K——
2026-03-10Parikh AsitBuy40.00K——
2026-03-10Parikh AsitSell40.00K——
2026-02-27Breedlove Robert CharlesBuy2.79K——
2026-02-27Breedlove Robert CharlesSell964$12.5612.11K
2026-02-27Breedlove Robert CharlesSell414$12.565.20K
2026-02-27Breedlove Robert CharlesBuy13.00K——
2026-02-10Cook Anne MarieBuy3.46K——
2026-02-10Cook Anne MarieSell1.53K$12.8219.68K
2026-02-10Basta Steven LBuy12.36K——
2026-02-10Basta Steven LSell6.28K$12.8280.47K
2026-01-23Parikh AsitBuy80.50K——
2026-01-23Parikh AsitSell80.50K——
2026-01-21Breedlove Robert CharlesSell776$13.6110.56K
2026-01-13Parikh AsitBuy8.75K$10.3090.12K
2026-01-13Parikh AsitSell8.75K$10.3090.12K
2026-01-02Basta Steven LBuy251.03K——
2026-01-02Basta Steven LBuy226.16K$15.713.55M
2026-01-02Cook Anne MarieBuy75.34K——
2026-01-02Cook Anne MarieBuy67.88K$15.711.07M
2026-01-02Narula SanjeevBuy82.72K——
2026-01-02Narula SanjeevBuy42.85K$15.71673.14K
2025-12-19Parikh AsitBuy8.75K$10.3090.12K
2025-12-19Parikh AsitSell8.75K$10.3090.12K
2025-12-18Breedlove Robert CharlesSell230$16.283.74K
2025-12-17Cook Anne MarieBuy17.37K——
2025-12-17Cook Anne MarieSell7.70K$15.36118.32K
2025-12-17Basta Steven LBuy62.04K——
2025-12-17Basta Steven LSell31.50K$15.36483.87K
2025-11-28Basta Steven LSell90.00K——
2025-11-28Basta Steven LBuy90.00K——
2025-11-28Basta Steven LSell48.38K$15.62755.62K
2025-11-03Breedlove Robert CharlesSell524$13.517.08K
2025-10-06Narula SanjeevBuy144.00K——
2025-10-06Narula SanjeevBuy200.00K$11.612.32M
2025-10-06Narula SanjeevOther0——
2025-09-25Basta Steven LSell90.00K——
2025-09-25Basta Steven LBuy90.00K——
2025-09-25Basta Steven LSell48.38K$11.66564.05K
2025-09-05Breedlove Robert CharlesSell461$12.095.57K
2025-07-16Breedlove Robert CharlesSell1.69K$8.3614.15K
2025-06-23Cook Anne MarieBuy210.00K$9.471.99M
2025-06-23Cook Anne MarieOther0——
2025-06-03KARBE FRANKBuy10.50K——
2025-06-03KARBE FRANKBuy17.50K$4.9586.62K
2025-06-03COLA MICHAEL FBuy10.50K——
2025-06-03COLA MICHAEL FBuy17.50K$4.9586.62K
2025-06-03Topper James NBuy10.50K——
2025-06-03Topper James NBuy17.50K$4.9586.62K
2025-06-03FIELDS HEIDIBuy10.50K——
2025-06-03FIELDS HEIDIBuy17.50K$4.9586.62K
2025-06-03Stenhouse MarkBuy10.50K——
2025-06-03Stenhouse MarkBuy17.50K$4.9586.62K
2025-06-03Parikh AsitBuy10.50K——
2025-06-03Parikh AsitBuy17.50K$4.9586.62K
2025-05-21Topper James NBuy3.78K$3.8614.61K
2025-05-19Breedlove Robert CharlesBuy33.00K$4.39144.87K
2025-05-14Topper James NBuy6.30K$3.3220.92K
2025-05-13Topper James NBuy1.12K$3.163.54K
2025-05-12Topper James NBuy12.60K$3.0438.30K
2025-05-09Topper James NBuy2.23K$3.628.05K
2025-05-09Topper James NBuy33.38K$3.19106.56K
2025-05-07Parikh AsitBuy5.00K$2.4011.98K
2025-05-06Parikh AsitBuy5.00K$2.6013.00K
2025-05-01Breedlove Robert CharlesOther0——
2025-05-01Breedlove Robert CharlesOther0——
2025-05-01Breedlove Robert CharlesOther13.50K$8.35112.72K
2025-05-01Breedlove Robert CharlesOther12.00K$15.21182.52K
2025-05-01Breedlove Robert CharlesOther15.75K$7.60119.70K
2025-05-01Breedlove Robert CharlesOther15.00K$5.7686.40K
2025-04-16Schroeder Theodore RBuy35.00K$4.23148.05K
2025-04-16Schroeder Theodore RBuy21.00K——
2025-04-16Schroeder Theodore ROther0——
2025-04-07Henderson MollySell3.68K$4.5516.74K
2025-04-03Basta Steven LBuy1.08M$5.015.44M
2025-04-03Basta Steven LBuy360.00K——
2025-04-01Basta Steven LOther0——
2025-03-13Parikh AsitBuy10.00K$4.4244.20K
2025-02-27Curran TerrieBuy342.50K$5.761.97M
2025-02-27Henderson MollyBuy72.00K——
2025-02-27Henderson MollyBuy50.00K$5.76288.00K
2025-02-27Nabulsi AzmiBuy79.20K——
2025-02-27Nabulsi AzmiBuy55.00K$5.76316.80K
2025-01-21Henderson MollySell6.58K$6.5943.37K
2025-01-21Nabulsi AzmiSell7.89K$6.5951.96K
2025-01-21Curran TerrieSell19.11K$6.59125.88K
2024-12-19Nabulsi AzmiSell1.12K$8.008.94K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 173, holders -6 vs prior quarter. Ownership 86.56%.

HolderSharesChangeChange %Value
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.12.47M00.00%135.26M
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD7.46M00.00%80.99M
BLACKROCK, INC.4.53M463.13K+11.40%49.10M
INVESCO LTD.4.03M-292.33K-6.76%43.72M
CARLYLE GROUP INC.3.50M00.00%37.94M
MILLENNIUM MANAGEMENT LLC3.38M-647.08K-16.08%36.63M
VANGUARD CAPITAL MANAGEMENT LLC2.66M73.31K+2.84%28.83M
GW&K INVESTMENT MANAGEMENT, LLC2.17M745.73K+52.48%23.51M
FRANKLIN TEMPLETON INC1.97M976.32K+98.17%21.38M
NEA MANAGEMENT COMPANY, LLC1.96M00.00%21.27M
683 CAPITAL MANAGEMENT, LLC1.85M00.00%20.07M
GOLDMAN SACHS GROUP INC1.78M1.15M+183.94%19.29M
STATE STREET CORP1.59M199.43K+14.38%17.21M
CATALYS PACIFIC, LLC1.49M00.00%16.21M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.1.46M257.37K+21.35%15.87M
GEODE CAPITAL MANAGEMENT, LLC1.32M-12.36K-0.93%14.28M
WASATCH ADVISORS LP1.31M-33.67K-2.51%14.18M
ENSIGN PEAK ADVISORS, INC1.05M-575.89K-35.38%11.41M
PROPEL BIO MANAGEMENT, LLC1.05M209.09K+24.85%11.40M
POINT72 ASSET MANAGEMENT, L.P.1.02M1.02MNew11.09M
VANGUARD PORTFOLIO MANAGEMENT LLC796.63K130.60K+19.61%8.64M
SUMMITTX CAPITAL, L.P.789.55K-206.34K-20.72%8.57M
HSBC HOLDINGS PLC709.70K709.70KNew7.70M
MARSHALL WACE, LLP666.09K-194.60K-22.61%7.23M
ECOR1 CAPITAL, LLC625.00K00.00%6.78M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Phathom Pharmaceuticals (PHAT) Stock Insights

PHAT$6.28+0.29 +4.84%

$508.06M

Market Cap

-4.48

P/E

8.76

Forward P/E

68

Score

Price History